Samalin Investment Counsel, LLC Novo Nordisk A S Transaction History

Samalin Investment Counsel, LLC

$222 Million
Q3 2024

A detailed history of Samalin Investment Counsel, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 7,529 shares of NVO stock, worth $639,965. This represents 0.4% of its overall portfolio holdings.

Number of Shares

7,529

Previous 8,004 5.93%

Holding current value

$639,965

Previous $1.14 Million 21.54%

% of portfolio

0.4%

Previous 0.55%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $56,558 - $69,074	-475 Reduced 5.93%	7,529 $896,000
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $858 - $1,028	7 Added 0.09%	8,004 $1.14 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $12,865 - $17,125	126 Added 1.6%	7,997 $1.03 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $21,154 - $25,413	-241 Reduced 2.97%	7,871 $814,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $365,033 - $800,953	4,014 Added 97.95%	8,112 $737,000
Q2 2023 Aug 03, 2023	SELL	$155.98 - $172.65 $155 - $172	-1 Reduced 0.02%	4,098 $663,000
Q1 2023 May 09, 2023	BUY	$132.34 - $159.14 $2,382 - $2,864	18 Added 0.44%	4,099 $652,000
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $20,304 - $26,795	-198 Reduced 4.63%	4,081 $552,000
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $7,527 - $9,237	-79 Reduced 1.81%	4,279 $426,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $5,265 - $6,212	51 Added 1.18%	4,358 $486,000
Q4 2021 Oct 13, 2022	SELL	$95.88 - $117.08 $1,438 - $1,756	-15 Reduced 0.35%	4,307 $482,000
Q4 2021 Feb 15, 2022	SELL	$95.88 - $117.08 $1,438 - $1,756	-15 Reduced 0.35%	4,307 $482 Million
Q3 2021 Oct 13, 2022	BUY	$84.42 - $106.62 $13,169 - $16,632	156 Added 3.74%	4,322 $415,000
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $13,169 - $16,632	156 Added 3.74%	4,322 $415 Million
Q2 2021 Oct 13, 2022	SELL	$67.66 - $84.76 $4,668 - $5,848	-69 Reduced 1.63%	4,166 $349,000
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $3,180 - $3,983	-47 Reduced 1.12%	4,166 $348,000
Q1 2021 May 11, 2021	SELL	$67.06 - $75.82 $1,475 - $1,668	-22 Reduced 0.52%	4,213 $284,000
Q4 2020 Oct 13, 2022	SELL	$63.89 - $73.8 $6,197 - $7,158	-97 Reduced 2.24%	4,235 $296,000
Q4 2020 Feb 09, 2021	SELL	$63.89 - $73.8 $6,197 - $7,158	-97 Reduced 2.24%	4,235 $296 Million
Q3 2020 Oct 13, 2022	SELL	$63.69 - $70.22 $1,655 - $1,825	-26 Reduced 0.6%	4,332 $301,000
Q3 2020 Nov 10, 2020	BUY	$63.69 - $70.22 $7,515 - $8,285	118 Added 2.8%	4,332 $300,000
Q2 2020 Aug 05, 2020	SELL	$58.54 - $67.94 $245,516 - $284,940	-4,194 Reduced 49.88%	4,214 $275,000
Q1 2020 May 04, 2020	SELL	$49.46 - $64.78 $2,473 - $3,239	-50 Reduced 0.59%	8,408 $506,000
Q4 2019 Feb 05, 2020	BUY	$49.86 - $58.26 $421,715 - $492,763	8,458 New	8,458 $489,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Novo Nordisk A S Transaction History